In neuroblastoma, the PI3/Akt/mTOR pathway has been found to affect multiple pathways/proteins to enhance the neuroblastoma phenotype, such as stabilizing MYCN, which in turn facilitates processes associated with malignancy like proliferation, angiogenesis, and metabolic reprogramming (11, 12). Here, AKT1 is linked to neuroblastoma.